Mineralys Therapeutics Inc (MLYS) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Mineralys Therapeutics Inc   (NASDAQ: MLYS)


Mineralys Therapeutics Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Mineralys Therapeutics Inc's ROI in the second quarter of 2026?
Mineralys Therapeutics Inc recorded a cumulative net loss of $-350 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -55.71%.

Within the Healthcare sector 501 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 2069 to 3462.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM 131.68 % 105.2 % 79.51 % 29.79 % -3.56 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 649 638 647 576 314
Return On Investment (TTM) -55.71 % -27.92 % -32.94 % -48.18 % -70.44 %
MLYS's Overall Ranking # 3462 # 2069 # 2695 # 3195 # 3182
Seq. Investment Change TTM 15.4 % 15.79 % 32.01 % 31.34 % 2.21 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -350 -152 -155 -171 -191

MLYS Company Profile >> Back to MLYS Roi Comparisons >> See Annual MLYS Return On Investment



Return On Investment MLYS's Ranking
Within: No.
Industry # 216
Sector # 502
Overall # 3462

Return On Investment Statistics
High Average Low
-17.05 %
-45.74 %
-71.15 %
(Mar 31 2023)   (Mar 31 2025)







Financial Statements
Mineralys Therapeutics Inc's II. Quarter Investments $ 649 Millions MLYS's Balance sheet
Mineralys Therapeutics Inc's II. Quarter Income $ -241 Millions Quarterly MLYS's Income Statement
MLYS's Income by Division See MLYS's Income by Division


MLYS Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023

Total Investments in Millions 647 191 241 0 0
Y / Y Investment Growth 238.13 % -20.69 % - - -
Net Income in Millions -155 -178 -72 0 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment -23.91 % -92.97 % -29.81 % - -


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
MLYS's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for MLYS's Competitors
Subscribers only: Roi for Mineralys Therapeutics Inc's Suppliers
Subscribers only: Return On Investment for MLYS's Customers

Other Ratios
MLYS's Roa MLYS's Inventory Turnover Ratio MLYS's Growth Rates MLYS's Dividend Statistics
MLYS's Profitability Ratios MLYS's Asset Turnover Ratio MLYS's Dividend Growth
MLYS's Roe MLYS's Valuation Ratios MLYS's Financial Strength Ratios MLYS's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-09-08T21:02:24+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.